<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="da585354-87e0-4f8c-90e9-3cbc3496a27a"><labelDrug name="TAMBOCOR"><Normalization><mmtx cui="C0592158" preferredWord="Tambocor" semType="phsu, orch"/></Normalization></labelDrug><generic name="flecainide acetate"/><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1" text="Drug Label for drug brand TAMBOCOR, containing flecainide acetate." type="negative"><entity charOffset="26:34" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.0" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="Drug Label for drug brand TAMBOCOR," preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="47:65" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.1" text="flecainide acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0086303" phraseText="flecainide acetate." preferredWord="Flecainide Acetate" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand TAMBOCOR," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.0" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.1"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.2" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.0"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.2" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.1.e.1"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.3" text="TAMBOCOR is contraindicated in patients with pre-existing second- or third-degree AV block, or with right bundle branch block when associated with a left hemiblock (bifascicular block), unless a pacemaker is present to sustain the cardiac rhythm should complete heart block occur. " type="negative"><entity charOffset="0:8" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.3.e.0" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="219:226" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.3.e.1" text="sustain" type="Biomedical_Entity"><Normalization><mmtx cui="C2732140" phraseText="sustain" preferredWord="Sustain" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.3.e.0" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.3.e.1"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.18" text="As with other Class I agents, patients treated with TAMBOCOR for atrial flutter have been reported with 1:1 atrioventricular conduction due to slowing the atrial rate. " type="negative"><entity charOffset="52:60" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.18.e.0" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="treated with TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="20:28" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.18.e.1" text="i agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0047291" phraseText="As with other Class I agents," preferredWord="3-chloro-4,4-dimethyl-2-oxazolidinone" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.18.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.18.e.0"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.20" text="Concomitant negative chronotropic therapy such as digoxin or beta-blockers may lower the risk of this complication." type="negative"><entity charOffset="50:57" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.20.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="Concomitant negative chronotropic therapy such as digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="61:74" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.20.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.20.e.0" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.20.e.1"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23" text="TAMBOCOR has been administered to patients receiving digitalis preparations or beta-adrenergic blocking agents without adverse effects. " type="negative"><entity charOffset="53:75" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.0" text="digitalis preparations" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="digitalis preparations" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.1" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="79:110" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.2" text="beta-adrenergic blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents without adverse effects." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.0"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.0" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.2"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.23.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24" lineNumber="20" text="During administration of multiple oral doses of TAMBOCOR to healthy subjects stabilized on a maintenance dose of digoxin, a 13% - 19% increase in plasma digoxin levels occurred at six hours postdose." type="regular"><entity charOffset="134:152|161:167" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.0" text="increase in plasma levels" type="Increase_Interaction"/><entity charOffset="153:160" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="a 13% - 19% increase in plasma digoxin levels" preferredWord="Digoxin" semType="strd, phsu, carb"/><mmtx cui="C0012265" phraseText="a 13% - 19% increase in plasma digoxin levels" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="34:56" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.3" text="oral doses of TAMBOCOR" type="Drug"><Normalization><mmtx cui="C0592158" phraseText="of TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.3" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.2" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.24.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25" lineNumber="21" text="In a study involving healthy subjects receiving TAMBOCOR and propranolol concurrently, plasma flecainide levels were increased about 20% and propranolol levels were increased about 30% compared to control values. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="94:104" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.4" text="flecainide" type="Expression"/><antecedentEntity charOffset="48-56" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.6" text="TAMBOCOR" type="Drug"/></anaphoraRelation><entity charOffset="87:93|105:126" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.0" text="plasma levels were increased" type="Increase_Interaction"/><entity charOffset="153:174" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.2" text="levels were increased" type="Increase_Interaction"/><entity charOffset="141:152" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.5" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="propranolol levels" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="48:56" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.6" text="TAMBOCOR" type="Drug"><Normalization><mmtx cui="C0592158" phraseText="TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="61:72" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.7" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="propranolol concurrently," preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.ddi.2"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.7" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.4" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.6" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.5" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.25.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26" lineNumber="21" text="In this formal interaction study, TAMBOCOR and propranolol were each found to have negative inotropic effects, when the drugs were administered together, the effects were additive. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="154:165" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.2" text="the effects" type="Expression"/><antecedentEntity charOffset="83-109" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.3" text="negative inotropic effects" type="SPAN"/></anaphoraRelation><entity charOffset="154:179" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.0" text="the effects were additive" type="Specific_Interaction"/><entity charOffset="83:109" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.3" text="negative inotropic effects" type="SPAN"/><entity charOffset="34:42" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.5" text="TAMBOCOR" type="Drug"><Normalization><mmtx cui="C0592158" phraseText="TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="47:58" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.6" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.0"><relations><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.5" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.6" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.26.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.27" text="The effects of concomitant administration of TAMBOCOR and propranolol on the PR interval were less than additive. " type="negative"><entity charOffset="58:69" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.27.e.0" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="propranolol on the PR interval" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="45:53" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.27.e.1" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="The effects of concomitant administration of TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.27.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.27.e.0"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.28" text="In TAMBOCOR clinical trials, patients who were receiving beta blockers concurrently did not experience an increased incidence of side effects. " type="negative"><entity charOffset="3:11" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.28.e.0" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="In TAMBOCOR clinical trials," preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="57:70" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.28.e.1" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="receiving beta blockers concurrently" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.28.e.0" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.28.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29" lineNumber="21" text="Nevertheless, the possibility of additive negative inotropic effects of beta blockers and flecainide should be recognized." type="regular"><entity charOffset="33:68" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.0" text="additive negative inotropic effects" type="Specific_Interaction"/><entity charOffset="72:85" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.2" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="the possibility of additive negative inotropic effects of beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="90:100" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.3" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.2" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.3" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.29.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.31" text="In vitro studies with several drugs which may be administered concomitantly showed that the extent of flecainide binding to human plasma proteins is either unchanged or only slightly less. " type="negative"><entity charOffset="124:136" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.31.e.0" text="human plasma" type="Biomedical_Entity"><Normalization><mmtx cui="C0544357" phraseText="to human plasma proteins" preferredWord="Human plasma" semType="phsu"/><RxNorm RxCui="831503"/></Normalization></entity><entity charOffset="102:112" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.31.e.1" text="flecainide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016229" phraseText="the extent of flecainide binding" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.31.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.31.e.0"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.33" text="TAMBOCOR has been used in a large number of patients receiving diuretics without apparent interaction. " type="negative"><entity charOffset="63:72" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.33.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics without apparent interaction." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.33.e.1" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.33.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.33.e.0"/></sentence><sentence biomedicalEntities="5" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34" lineNumber="22" text="Limited data in patients receiving known enzyme inducers (phenytoin, phenobarbital, carbamazepine ) indicate only a 30% increase in the rate of flecainide elimination. " type="regular"><entity charOffset="120:143|155:166" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.0" text="increase in the rate of elimination" type="Decrease_Interaction"/><entity charOffset="144:154" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.2" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="a 30% increase in the rate of flecainide elimination." preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="41:56" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.3" text="enzyme inducers" type="Drug_Class"><Normalization><RxNorm RxCui="3960"/></Normalization></entity><entity charOffset="58:67" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.4" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="(phenytoin," preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="69:82" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.5" text="phenobarbital" type="Drug"><Normalization><mmtx cui="C0031412" phraseText="phenobarbital," preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><entity charOffset="84:97" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.6" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine" preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><drugClassMembership drug="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.4" drugClass="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.3"/><drugClassMembership drug="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.5" drugClass="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.3"/><drugClassMembership drug="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.6" drugClass="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.3"/><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.3" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.2" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.34.e.0" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35" lineNumber="22" text="In healthy subjects receiving cimetidine (1 gm daily) for one week, plasma flecainide levels increased by about 30% and half-life increased by about 10%." type="regular"><entity charOffset="68:74|86:102" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.0" text="plasma levels increased" type="Increase_Interaction"/><entity charOffset="75:85" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.2" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="plasma flecainide levels" preferredWord="Flecainide" semType="phsu, orch"/><mmtx cui="C0016229" phraseText="plasma flecainide levels" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="120:139" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.3" text="half-life increased" type="Increase_Interaction"/><entity charOffset="30:40" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.5" text="cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.ddi.2"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.5" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.2" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.35.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36" lineNumber="23" text="When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced. " type="regular"><entity charOffset="48:54|66:85" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.0" text="plasma levels may increase" type="Increase_Interaction"/><entity charOffset="55:65" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.2" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="plasma flecainide levels" preferredWord="Flecainide" semType="phsu, orch"/><mmtx cui="C0016229" phraseText="plasma flecainide levels" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="5:15" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.3" text="amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.0"><relations><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.3" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.2" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.36.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38" lineNumber="24" text="Drugs that inhibit cytochrome P450IID6, such as quinidine, might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy, especially if these patients are extensive metabolizers." type="regular"><entity charOffset="65:99" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.0" text="increase the plasma concentrations" type="Increase_Interaction"/><entity charOffset="0:38" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.2" text="Drugs that inhibit cytochrome P450IID6" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="48:57" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.3" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="such as quinidine," preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="103:113" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.5" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="the plasma concentrations of flecainide" preferredWord="Flecainide" semType="phsu, orch"/><mmtx cui="C0016229" phraseText="the plasma concentrations of flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><drugClassMembership drug="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.3" drugClass="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.2"/><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.0"><relations><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.2" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.5" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.38.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39" text="There has been little experience with the coadministration of TAMBOCOR and either disopyramide or verapamil. " type="negative"><entity charOffset="82:94" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.0" text="disopyramide" type="Biomedical_Entity"><Normalization><mmtx cui="C0012702" phraseText="either disopyramide" preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.1" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="little experience with the coadministration of TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="98:107" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.2" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.0"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.0" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.2"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.39.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40" lineNumber="25" text="Because both of these drugs have negative inotropic properties and the effects of coadministration with TAMBOCOR are unknown, neither disopyramide nor verapamil should be administered concurrently with TAMBOCOR unless, in the judgment of the physician, the benefits of this combination outweigh the risks. " type="regular"><entity charOffset="126:133|161:196" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.0" text="neither should be administered concurrently" type="Caution_Interaction"/><entity charOffset="202:210" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.2" text="TAMBOCOR" type="Drug"><Normalization><mmtx cui="C0592158" phraseText="concurrently with TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="134:146" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.3" text="disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="neither disopyramide nor verapamil" preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="151:160" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="neither disopyramide nor verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.ddi.1"><interaction trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.0"><relations><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.4" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.2" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.3" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.2" trigger="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.40.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41" text="There has been too little experience with the coadministration of TAMBOCOR with nifedipine or diltiazem to recommend concomitant use." type="negative"><entity charOffset="94:103" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.0" text="diltiazem" type="Biomedical_Entity"><Normalization><mmtx cui="C0012373" phraseText="diltiazem to" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="66:74" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.1" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="too little experience with the coadministration of TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="80:90" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.2" text="nifedipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028066" phraseText="with nifedipine" preferredWord="Nifedipine" semType="phsu, orch"/><RxNorm RxCui="7417"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.0"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.2" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.0"/><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.41.e.2"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.54" text="Results from a multiple dose study conducted in mothers soon after delivery indicates that flecainide is excreted in human breast milk in concentrations as high as 4 times (with average levels about 2.5 times) corresponding plasma levels, assuming a maternal plasma level at the top of the therapeutic range (1 g/mL), the calculated daily dose to a nursing infant (assuming about 700 mL breast milk over 24 hours) would be less than 3 mg." type="negative"><entity charOffset="117:134" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.54.e.0" text="human breast milk" type="Biomedical_Entity"><Normalization><mmtx cui="C0885503" phraseText="excreted in human breast milk" preferredWord="human breast milk" semType="phsu, orch"/><RxNorm RxCui="831503"/></Normalization></entity><entity charOffset="91:101" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.54.e.1" text="flecainide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016229" phraseText="that flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.54.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.54.e.0"/></sentence><sentence id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.58" text="Since flecainide elimination from plasma can be markedly slower in patients with significant hepatic impairment, TAMBOCOR should not be used in such patients unless the potential benefits clearly outweigh the risks. " type="negative"><entity charOffset="113:121" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.58.e.0" text="tambocor" type="Biomedical_Entity"><Normalization><mmtx cui="C0592158" phraseText="TAMBOCOR" preferredWord="Tambocor" semType="phsu, orch"/><RxNorm RxCui="152403"/></Normalization></entity><entity charOffset="6:16" id="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.58.e.1" text="flecainide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016229" phraseText="flecainide elimination from plasma" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><pair ddi="false" e1="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.58.e.1" e2="Dailymed.da585354-87e0-4f8c-90e9-3cbc3496a27a.s.58.e.0"/></sentence><positiveExamples number="11"/><negativeExamples number="21"/></document>